Esquire Financial Holdings
ESQ · NASDAQ
About ESQ
- Employees
- 151
- Headquarters
- Jericho, New York
- Listed
- Jun 27, 2017
- Sector
- Financials
- Industry
- Banks
ESQ key statistics
- Market cap
- 1.44B
- Price-earnings ratio
- 19.26
- Dividend yield
- 0.44%
- Average volume
- 138.19K
- Volume
- 121.82K
- Open price
- $117.62
- High today
- $121.00
- Low today
- $117.50
- 52 Week high
- $134.82
- 52 Week low
- $92.10
Esquire Financial Holdings (ESQ) at a glance
Esquire Financial Holdings (ESQ) last traded at $119.21, with a market cap of 1.44B, a price-to-earnings ratio of 19.26 and a dividend yield of 0.44%.
Today the stock has traded between $117.50 and $121.00. The current price is 1.5% above the day's low and 1.5% below its high.
Volume so far is 121.82K shares, in line with the average of 138.19K shares a day.
Over the past year Esquire Financial Holdings has ranged from $92.10 to $134.82, and now sits 63% of the way up that range.
Esquire Financial Holdings met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $1.60 per share against an estimate of $1.59.
The average analyst price target is $132.60, 11.2% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy66.7%
- Hold33.3%
- Sell0.0%
- Low
- $126.25
- Now
- $119.21
- High
- $147.00
ESQ earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 2.4% on average.
- Q3 FY24: reported $1.34 per share against an estimate of $1.32
- Q4 FY24: reported $1.37 per share against an estimate of $1.39
- Q1 FY25: reported $1.33 per share against an estimate of $1.33
- Q2 FY25: reported $1.38 per share against an estimate of $1.40
- Q3 FY25: reported $1.62 per share against an estimate of $1.48
- Q4 FY25: reported $1.55 per share against an estimate of $1.55
- Q1 FY26: reported $1.58 per share against an estimate of $1.55
- Q2 FY26: reported $1.60 per share against an estimate of $1.59
ESQ news
- Press releasePRNewswire
- Press releasePRNewswire
Esquire Bank Named a Top Deposit Franchise by S&P Global Market Intelligence for Third Consecutive Year
- Press releasePRNewswire
Esquire Financial Holdings Ranks #3 Among Top-Performing U.S. Banks in Bank Director's 2026 RankingBanking
- Press releasePRNewswire
Esquire Financial Holdings, Inc. Completes Acquisition of Signature Bancorporation, Inc. on August 1, 2026
- Press releasePRNewswire
Esquire Financial Holdings, Inc. Declares Regular Quarterly Dividend For Common Stockholders
- Press releasePRNewswire
Esquire Financial Holdings, Inc. Reports Second Quarter 2026 Results
- Press releasePRNewswire
Esquire Financial Holdings, Inc. Announces Second Quarter 2026 Earnings Release and Conference Call on July 23, 2026
- Press releasePRNewswire
Esquire Bank Named #1 Best Law Firm Funding Provider in The Recorder's "Best Of" Survey
Similar companies
Companies in the same industry as Esquire Financial Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.